Li Yang

1PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 26, 2026
AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

Pageof 1

Frequent Collaborators

1 joint publications

Terufumi Kato

1 joint publications

Antonin Levy

1 joint publications

Alexander I Spira

1 joint publications

Jie Wang